David Owerbach

3.9k total citations
63 papers, 3.2k citations indexed

About

David Owerbach is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, David Owerbach has authored 63 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 26 papers in Genetics and 24 papers in Surgery. Recurrent topics in David Owerbach's work include Pancreatic function and diabetes (24 papers), Diabetes and associated disorders (18 papers) and Metabolism, Diabetes, and Cancer (14 papers). David Owerbach is often cited by papers focused on Pancreatic function and diabetes (24 papers), Diabetes and associated disorders (18 papers) and Metabolism, Diabetes, and Cancer (14 papers). David Owerbach collaborates with scholars based in United States, Denmark and Sweden. David Owerbach's co-authors include Kenneth H. Gabbay, William J. Rutter, Kurt M. Bohren, Ricardo Azziz, Thomas B. Shows, Didier Dewailly, Åke Lernmark, Jian H. Song, Carmen Quinto and Murray Korc and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

David Owerbach

63 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Owerbach United States 32 1.6k 1.3k 914 870 588 63 3.2k
Leslie B. Rall United States 16 1.5k 0.9× 568 0.4× 869 1.0× 567 0.7× 137 0.2× 21 2.8k
Kyeong Cheon Jung South Korea 31 864 0.5× 310 0.2× 711 0.8× 608 0.7× 861 1.5× 132 3.0k
Henri‐Jean Garchon France 32 901 0.6× 839 0.6× 211 0.2× 301 0.3× 990 1.7× 92 3.1k
Somayyeh Fahiminiya Canada 27 1.2k 0.7× 811 0.6× 166 0.2× 226 0.3× 183 0.3× 52 2.2k
Terry L. Delovitch Canada 32 759 0.5× 1.3k 1.0× 382 0.4× 739 0.8× 2.7k 4.6× 78 3.8k
Claude Besmond France 26 952 0.6× 286 0.2× 177 0.2× 242 0.3× 143 0.2× 72 1.9k
Akiko Furuya Japan 26 1.9k 1.2× 332 0.3× 116 0.1× 333 0.4× 460 0.8× 65 3.0k
Robert S. Wildin United States 19 589 0.4× 794 0.6× 223 0.2× 235 0.3× 2.1k 3.5× 31 3.0k
T L Delovitch Canada 25 536 0.3× 1.0k 0.8× 408 0.4× 615 0.7× 1.5k 2.5× 74 2.5k
W Northemann Germany 18 614 0.4× 241 0.2× 133 0.1× 224 0.3× 436 0.7× 32 1.5k

Countries citing papers authored by David Owerbach

Since Specialization
Citations

This map shows the geographic impact of David Owerbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Owerbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Owerbach more than expected).

Fields of papers citing papers by David Owerbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Owerbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Owerbach. The network helps show where David Owerbach may publish in the future.

Co-authorship network of co-authors of David Owerbach

This figure shows the co-authorship network connecting the top 25 collaborators of David Owerbach. A scholar is included among the top collaborators of David Owerbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Owerbach. David Owerbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bohren, Kurt M., Kenneth H. Gabbay, & David Owerbach. (2007). Affinity chromatography of native SUMO proteins using His-tagged recombinant UBC9 bound to Co2+-charged talon resin. Protein Expression and Purification. 54(2). 289–294. 21 indexed citations
2.
Owerbach, David, Eileen McKay, Edward T.H. Yeh, Kenneth H. Gabbay, & Kurt M. Bohren. (2005). A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochemical and Biophysical Research Communications. 337(2). 517–520. 199 indexed citations
3.
4.
Owerbach, David, et al.. (2004). Association of a CAG/CAA repeat sequence in the TBP gene with type I diabetes. Biochemical and Biophysical Research Communications. 323(3). 865–869. 3 indexed citations
5.
6.
Owerbach, David, Francisco J. Naya, Ming‐Jer Tsai, et al.. (1997). Analysis of Candidate Genes for Susceptibility to Type I Diabetes: A Case-Control and Family-Association Study of Genes on Chromosome 2q31–35. Diabetes. 46(6). 1069–1074. 33 indexed citations
7.
Owerbach, David & Kenneth H. Gabbay. (1996). The Search for IDDM Susceptibility Genes: The Next Generation. Diabetes. 45(5). 544–551. 59 indexed citations
8.
Azziz, Ricardo & David Owerbach. (1995). Molecular abnormalities of the 21-hydroxylase gene in hyperandrogenic women with an exaggerated 17-hydroxyprogesterone response to short-term adrenal stimulation. American Journal of Obstetrics and Gynecology. 172(3). 914–918. 23 indexed citations
9.
Owerbach, David, et al.. (1992). Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction. Human Genetics. 89(1). 109–110. 11 indexed citations
10.
Reveille, John D., et al.. (1992). Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma).. Journal of Clinical Investigation. 89(4). 1208–1213. 70 indexed citations
11.
Owerbach, David, et al.. (1992). Pro-453 to Ser mutation in CYP21 is associated with nonclassic steroid 21-hydroxylase deficiency.. Molecular Endocrinology. 6(8). 1211–1215. 69 indexed citations
12.
Owerbach, David, et al.. (1990). Direct Analysis of CYP21B Genes in 21-Hydroxylase Deficiency using Polymerase Chain Reaction Amplification. Molecular Endocrinology. 4(1). 125–131. 67 indexed citations
13.
Owerbach, David, et al.. (1988). Oligonucleotide probes for HLA-DQA and DQB genes define susceptibility to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 31(10). 751–757. 30 indexed citations
14.
Owerbach, David, et al.. (1987). Molecular biology of the HLA system in insulin‐dependent diabetes mellitus. Diabetes/Metabolism Reviews. 3(3). 819–833. 5 indexed citations
15.
Owerbach, David, et al.. (1986). Characterization of three HLA-DR beta genes isolated from an HLA-DR 3/4 insulin-dependent diabetic patient. Immunogenetics. 24(1). 41–46. 11 indexed citations
16.
Serjeantson, S. W., David Owerbach, Paul Zimmet, J. Nerup, & K Thoma. (1983). Genetics of diabetes in Nauru: Effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia. 25(1). 13–7. 67 indexed citations
17.
Owerbach, David, Åke Lernmark, Lars Rask, et al.. (1983). Detection of HLA-D/DR-related DNA polymorphism in HLA-D homozygous typing cells.. Proceedings of the National Academy of Sciences. 80(12). 3758–3761. 41 indexed citations
18.
Owerbach, David & Jørn Nerup. (1982). Restriction Fragment Length Polymorphism of the Insulin Gene in Diabetes Mellitus. Diabetes. 31(3). 275–277. 107 indexed citations
19.
Owerbach, David, Graeme I. Bell, William J. Rutter, J.A. Brown, & Thomas B. Shows. (1981). The Insulin Gene Is Located on the Short Arm of Chromosome 11 in Humans. Diabetes. 30(3). 267–270. 84 indexed citations
20.
Owerbach, David, Graeme I. Bell, William J. Rutter, & Thomas B. Shows. (1980). The insulin gene is located on chromosome 11 in humans. Nature. 286(5768). 82–84. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie B. Rall Breakdown of academic impact, for papers by Kyeong Cheon Jung Breakdown of academic impact, for papers by Henri‐Jean Garchon Breakdown of academic impact, for papers by Somayyeh Fahiminiya Breakdown of academic impact, for papers by Terry L. Delovitch Breakdown of academic impact, for papers by Claude Besmond Breakdown of academic impact, for papers by Akiko Furuya Breakdown of academic impact, for papers by Robert S. Wildin Breakdown of academic impact, for papers by T L Delovitch Breakdown of academic impact, for papers by W Northemann
Rankless by CCL
2026